Publicações Científicas 2023 - Janeiro a Dezembro

1. Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, et al. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions. N Engl J Med. 2023. 10.1056/NEJMoa2306441.


2. Zequim VC, Schick M, Gama RR, Gama MPR. Pancreatic adenocarcinoma is an exocrine malignant tumor which is responsible for > 90% of all pancreatic cancer. Endocrinologia & Diabetes Clínica e Experimental. 2023:2363 - 9.


3. Zantut-Wittmann DE, Laus AC, Moreno DA, Barreto IS, Moma CA, Maia FFR, et al. Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter. Am J Med Sci. 2023. 10.1016/j.amjms.2023.03.019.


4. Zantut-Wittmann DE, Barreto IS, Laus AC, Moreno DA, Moma CA, Maia FFR, et al. PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma. Mol Cell Endocrinol. 2023:111931. 10.1016/j.mce.2023.111931.


5. Zanon MF, Scapulatempo-Neto C, Gama RR, Marques MMC, Reis RM, Evangelista AF. Identification of MicroRNA Expression Profiles Related to the Aggressiveness of Salivary Gland Adenoid Cystic Carcinomas. Genes (Basel). 2023;14(6). 10.3390/genes14061220.


6. Zanon JR, Durante H, Nóbrega LM, Accorsi G, Pedrão PG, Dos Reis R. Emphysematous pyelonephritis after urinary diversion by percutaneous nephrostomy in patient with advanced cervical cancer: A case report. SAGE Open Med Case Rep. 2023;11:2050313x231182532. 10.1177/2050313x231182532.


7. Zampieri FG, Cavalcanti AB, Taniguchi LU, Lisboa TC, Serpa-Neto A, Azevedo LCP, et al. Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case-control study. Ann Intensive Care. 2023;13(1):32. 10.1186/s13613-023-01123-y.


8. Yu SL, Hsiao YJ, Cooper WA, Choi YL, Avilés-Salas A, Chou TY, et al. The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer. Pathology. 2023;55(1):19-30. 10.1016/j.pathol.2022.07.016.


9. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Res Sq. 2023. 10.21203/


10. Villela NC, Seber A, Macedo C, Zecchin VG, Guimarães R, Faria TMV, et al. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers. Pediatr Hematol Oncol. 2023:1-15. 10.1080/08880018.2023.2187497.


11. Vigorito AC, Miranda ECM, Colturato VAR, Funke VAM, Fatobene G, Mariano L, et al. Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival. Transplant Cell Ther. 2023. 10.1016/j.jtct.2023.01.007.


12. Vieira RAdC, Campos RES, Amorim MA, Silveira AD, Oliveira LCNd, José SA. Sequels associated with breast cancer treatment: what is important to measure in a report. Mastology. 2023;33:1-6. 10.29289/2594539420220050.


13. Vieira R, Sant'Anna D, Laus AC, Reis RM. Ancestry and self-reported race in Brazilian breast cancer women. Rev Assoc Med Bras (1992). 2023;69(12):e20230767. 10.1590/1806-9282.20230767.


14. Vieira R, Bailão-Junior A, de Oliveira-Junior I. Does breast oncoplastic surgery improve quality of life? Front Oncol. 2023;12:1099125. 10.3389/fonc.2022.1099125.


15. Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, et al. Functional pri-miR-34b/c rs4938723 and KRAS 3'UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome? Gene. 2023;898:148069. 10.1016/j.gene.2023.148069.


16. Vieira AGS, Puthenpura V, Krailo M, Fallahazad N, Brougham MFH, Murray MJ, et al. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium. Pediatr Blood Cancer. 2023:e30426. 10.1002/pbc.30426.


17. Vazquez FdL, Silveira HCS, Otero UB, Hosokawa TT, Fregnani JHTG, Longatto-Filho A, et al. The Usefulness of an Online Simplified Screening Questionnaire (SSQ) in Identifying Work-Related Cancers. Healthcare. 2023;11(11):1563. 10.3390/healthcare11111563.


18. van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, et al. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv. 2023;17(4):1111-30. 10.1007/s11764-021-01160-1.


19. Valentino TCO, Paiva CE, de Oliveira MA, Hui D, Bruera E, Julião M, et al. Preference and actual place-of-death in advanced cancer: prospective longitudinal study. BMJ Support Palliat Care. 2023. 10.1136/spcare-2023-004299.


20. Untergasser A, Hellemans J, Pfaffl MW, Ruijter JM, van den Hoff MJB, Dragomir MP, et al. Disclosing quantitative RT-PCR raw data during manuscript submission:a call for action. Mol Oncol. 2023. 10.1002/1878-0261.13418.


21. Uchida Miwa M, Paiva CE, Ferreira AJS, Julião M, Chochinov HM, Paiva BSR. Translation and cross-cultural adaptation of the Dignity Therapy Question Protocol to Brazilian Portuguese. Palliat Support Care. 2023:1-7. 10.1017/s147895152300041x.


22. Trevizan FB, Paiva CE, Julião M, de Oliveira Valentino TC, Miwa MU, Mingardi M, et al. Comprehension and Decision-Making Capacity Questionnaire About Palliative Care and Advance Care Planning: A Delphi Study. J Palliat Care. 2023;38(1):41-51. 10.1177/08258597221128676.


23. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2023:1-9. 10.1017/s1478951523001517.


24. Tostes K, Siqueira AP, Reis RM, Leal LF, Arantes LMBR. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability. International Journal of Molecular Sciences. 2023;24(15):11887. 10.3390/ijms241511887.


25. Tobias-Machado M, Ornellas AA, Hidaka AK, Medina LG, Mattos PAL, Besio RS, et al. Long-term oncological and surgical outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) in patients with penile cancer. Int Braz J Urol. 2023;49(5):580-9. 10.1590/s1677-5538.Ibju.2023.0065.


26. Teixeira AP, Haddad W, Jr., Barreto LO, Secaf A, Mermejo LM, Lucchesi FR, et al. Histogram analysis in the differentiation between adrenal adenomas and pheochromocytomas: the value of a single measurement. Radiol Bras. 2023;56(2):59-66. 10.1590/0100-3984.2022.0067.


27. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View. Healthcare (Basel). 2023;11(6). 10.3390/healthcare11060906.


28. Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Bergo RR, et al. Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study. Crit Care Sci. 2023;35(3):256-65. 10.5935/2965-2774.20230129-en.


29. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2023. 10.1016/j.jpurol.2023.10.014.


30. Sousa LR, Oliveira AGS, Arantes A, Junqueira JGM, Alexandre GP, Severino VGP, et al. Acetogenins-Rich Fractions of Annona coriacea Suppress Human Glioblastoma Viability and Migration by Regulating Necroptosis and MMP-2 Activity In Vitro. Molecules. 2023;28(9). 10.3390/molecules28093809.


31. Sorroche BP, Teixeira RJ, Pereira CAD, Santana IVV, Vujanovic L, Vazquez VL, et al. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil. Diagnostics (Basel). 2023;13(6). 10.3390/diagnostics13061041.


32. Solla Negrao EM, Cabello C, Conz L, Mauad EC, Zeferino LC, Vale DB. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area. J Med Screen. 2023;30(1):42-6. 10.1177/09691413221122055.


33. Singer S, Sykiotis G, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, et al. The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients. Endocrine. 2023. 10.1007/s12020-023-03628-9.


34. Singer S, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, Hammerlid E, et al. International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34. Thyroid. 2023. 10.1089/thy.2023.0221.


35. Silva VAO, Rosa MN, Gomes INF, Vital PDS, Alves ALV, Evangelista AF, et al. Bio-Prospecting of Crude Leaf Extracts from Thirteen Plants of Brazilian Cerrado Biome on Human Glioma Cell Lines. Molecules. 2023;28(3). 10.3390/molecules28031394.


36. Silva JM, Deus AJ, Vale AAM, Azevedo-Santos APS, Nogueira L, Laus AC, et al. MIR-376A-2-5P as a potential prognostic marker for advanced penile squamous cell carcinomas trough HPV-dependent pathways. Am J Cancer Res. 2023;13(11):5466-81.


37. Silva A, Félix A, Cerqueira M, Gonçalves CS, Sampaio-Marques B, Longatto-Filho A, et al. Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer. Pharmaceutics. 2023;15(12):2688.


38. Scuglia M, Frazão LP, Miranda A, Martins A, Barbosa-Sequeira J, Coimbra D, et al. Diaphragmatic hernia repair porcine model to compare the performance of biodegradable membranes against Gore-Tex(®). Pediatr Surg Int. 2023;40(1):7. 10.1007/s00383-023-05584-x.


39. Santos P, Granzotto FCN, Antunes HS, de Lima EM, Varanda RF, Maccari K, et al. Dentistry consensus on HSCT - Part III: Special topics - Dentistry on HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.004.


40. Santos MMD, Frasson AL, Silva VDD, Maciel ACA, Watte G, Werutsky G, et al. Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer. Rev Bras Ginecol Obstet. 2023;45(9):e535-e41. 10.1055/s-0043-1772486.


41. Santos FA, Reis RM, Barroti LC, Pereira AAL, Matsushita MM, de Carvalho AC, et al. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. J Gastrointest Cancer. 2023. 10.1007/s12029-023-00964-x.


42. Santos Carmo BD, de Camargos MG, Santos Neto MFD, Paiva BSR, Lucchetti G, Paiva CE. Relationship between religion/spirituality and the aggressiveness of cancer care: a scoping review. J Pain Symptom Manage. 2023. 10.1016/j.jpainsymman.2023.01.017.


43. Sales KDS, de Matos Mota AG, Gusmão CTP, Ribeiro Junior HL. Uncommon Foot Pain: A Rare Case of Sequential Migration of Cutaneous Pili Migrans. Int J Trichology. 2023;15(1):33-5. 10.4103/ijt.ijt_4_21.


44. Salaroli LB, Ferreira JRS, Prado CBD, De Podestá OPG, Carvalho AL, Mercante A, et al. Cumulative Coffee Consumption as a Protective Factor for Head and Neck Cancer in Brazil. Nutr Cancer. 2023;75(1):228-35. 10.1080/01635581.2022.2106377.


45. Sabaini P, Machado CM. Use of live viral vaccines after HCT: Still a lot to learn. Transpl Infect Dis. 2023:e14044. 10.1111/tid.14044.


46. Rocha BMM, Dolan RD, Paiva CE, McGovern J, Paiva BSR, Preto DD, et al. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer. J Pain Symptom Manage. 2023;65(4):348-57. 10.1016/j.jpainsymman.2022.11.021.


47. Ritter J, Allen S, Cohen PD, Fajardo AF, Marx K, Loggetto P, et al. Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncol. 2023;24(9):e364-e75. 10.1016/s1470-2045(23)00320-0.


48. Ribeiro Junior HL, Gonçalves PG, Moreno DA, Goes JVC, de Oliveira RTG, Montefusco-Pereira CV, et al. Discrepancy in transcriptomic profiling between CD34 + stem cells and primary bone marrow cells in myelodysplastic neoplasm. Leuk Res. 2023;129:107071. 10.1016/j.leukres.2023.107071.


49. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F. Thyroid Cancer Incidence and Mortality by Socioeconomic Level in the State of São Paulo, Brazil 2001-2017. Endocr Pract. 2023. 10.1016/j.eprac.2023.07.028.


50. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F. Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Med. 2023. 10.1002/cam4.6259.


51. Ribeiro AG, Costa AMd, Pereira TF, Guimarães DP, Fregnani JHTG. Colorectal cancer spatial pattern in the northeast region of São Paulo, Brazil. Global Epidemiology. 2023;5:100097. 10.1016/j.gloepi.2022.100097.


52. Quaioto BR, Borçoi AR, Mendes SO, Doblas PC, Dos Santos Vieira T, Arantes Moreno IA, et al. Tobacco use modify exon IV BDNF gene methylation levels in depression. J Psychiatr Res. 2023;159:240-8. 10.1016/j.jpsychires.2023.01.038.


53. Prieto TG, Baldavira CM, Machado-Rugolo J, Olivieri EHR, Silva E, Silva VG, et al. Clinical and morphological features of large-cell neuroendocrine carcinomas and small-cell lung carcinomas expressing the DLL3 and ASCL1 oncoproteins. Braz J Med Biol Res. 2023;56:e12921. 10.1590/1414-431X2023e12921.


54. Possati-Resende JC, Fritsch TZ, Souza KCB. Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy. Rev Bras Ginecol Obstet. 2023;45(11):e689-e98. 10.1055/s-0043-1772483.


55. Pombo-de-Oliveira MS, Petridou ET, Karalexi MA, Junqueira MER, Braga FHP, Bouzas LF, et al. The Interplay of Cesarean-Section Delivery and First-Birth Order as Risk Factors in Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2023;32(3):371-9. 10.1158/1055-9965.Epi-22-0664.


56. Poma MAM, Ribeiro Junior HL, Costa EA, Paier CRK, Brasil LL, Lima LB, et al. Effect of CYB2B6 (c.516G>T), CYP2C9 (c.1075A>C) and UGT1A9 (c.98T>C) polymorphisms on propofol pharmacokinetics in patients submitted to colonoscopy: a cohort study. Postgrad Med J. 2023;99(1170):286-95. 10.1136/postgradmedj-2021-141375.


57. Polachini GM, de Castro TB, Smarra LFS, Henrique T, de Paula CHD, Severino P, et al. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction. Sci Rep. 2023;13(1):8588. 10.1038/s41598-023-34808-2.


58. Pires SF, de Barros JS, da Costa SS, de Oliveira Scliar M, Van Helvoort Lengert A, Boldrini É, et al. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development. Mol Genet Genomics. 2023. 10.1007/s00438-023-02010-8.


59. Pires SF, Barros JS, Costa SSD, Carmo GBD, Scliar MO, Lengert AVH, et al. Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. Int J Mol Sci. 2023;24(13). 10.3390/ijms241310463.


60. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2023. 10.1007/s00405-023-08180-w.


61. Pinto MT, Eiras Martins G, Vieira AGS, Galvão JMS, de Pádua Souza C, Macedo C, et al. Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review. Cancers (Basel). 2023;15(11). 10.3390/cancers15112990.


62. Pinheiro JdA, Borçoi AR, Vitorino Freitas F, Mendes SO, Archanjo AB, Oliveira MMd, et al. Psychotropic drug use and suggestive depression symptoms associated with NR3C1 DNA methylation. Revista brasileira de crescimento e desenvolvimento humano. 2023;33(1):139-52. 10.36311/jhgd.v33.14300.


63. Pessini SA, Carvalho JP, Reis RD, Filho A, Primo W. Fertility preservation in gynecologic cancer patients. Rev Bras Ginecol Obstet. 2023;45(3):161-8. 10.1055/s-0043-1768564.


64. Peres SV, Arantes PE, Fagundes MA, Ab'Saber AM, Gimenes DL, Curado MP, et al. Molecular subtypes as a prognostic breast cancer factor in women users of the São Paulo public health system, Brazil. Rev Bras Epidemiol. 2023;26:e230028. 10.1590/1980-549720230028.


65. Pereira TF, Aranha VJ, Waldvogel BC, da Costa AM, Tavares Guerreiro Fregnani JH. Deterministic linkage for improving follow-up time in a Brazilian population-based cancer registry. Sci Rep. 2023;13(1):4816. 10.1038/s41598-023-31303-6.


66. Pereira LL, Veiga Siqueira Amorim D, Brito Sampaio W, Almeida Cruz Azevêdo T, Bispo Pereira Cardoso V, Barreto Lemos F, et al. Factors Associated with Periodontitis in Patients with and without HIV. Int J Dent. 2023;2023:9929835. 10.1155/2023/9929835.


67. Pelorca RJF, Oliveira-Junior I, Vieira RADC. Are there clinical and subclinical/pathological forms of Paget's disease of the breast? Frontiers in Oncology. 2023;13:1287882. 10.3389/fonc.2023.1287882.


68. Pelorca RJF, de Oliveira-Junior I, da Costa Vieira RA. Oncoplastic surgery for Paget's disease of the breast. Front Oncol. 2023;13:1151932. 10.3389/fonc.2023.1151932.


69. Pedro Amorim Neto D, Vitor Pereira de Godoy J, Tostes K, Pelegrini Bosque B, Vieira Rodrigues P, Aparecida Rocco S, et al. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance. Neuroscience. 2023. 10.1016/j.neuroscience.2023.06.010.


70. Pastrez PRA, Barbosa AM, Mariano VS, Causin RL, Castro AG, Torrado E, et al. Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2023;15(7). 10.3390/cancers15071997.


71. Paiva CE, Preto DD, de Lima C, Paiva BSR. To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers. Cancer Control. 2023;30:10732748231176639. 10.1177/10732748231176639.


72. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2023. 10.1093/oncolo/oyad284.


73. Paiva CE, Bonilla-Sierra P, Tripodoro VA, Rodríguez-Nunez A, De Simone G, Rodriguez LH, et al. How to Advance Palliative Care Research in South America? Findings From a Delphi Study. J Pain Symptom Manage. 2023;65(3):193-202. 10.1016/j.jpainsymman.2022.11.020.


74. Paiva BSR, Mingardi M, de Almeida LF, de Camargos MG, Valentino TCO, Julião M, et al. Go Wish card game-exploring end-of-life wishes of patients in oncology palliative care: a qualitative study. Ann Palliat Med. 2023. 10.21037/apm-23-381.


75. Paiva BSR, Lourenço BM, Prata HM, Valentino TCO, Oliveira MA, Santos Neto MFD, et al. Burial or cremation? Factors associated with preferences among patients with cancer in Brazil: a cross-sectional study. Sao Paulo Med J. 2023;141(6):e2022441. 10.1590/1516-3180.2022.0441.R1.13022023.


76. Pádua Souza Cd, Carneiro ASB, Oliveira Lessa ACd, Lacerda DC, Paiva CE, Zorzetto MMC, et al. Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial. Research Square. 2023. 10.21203/


77. Pacheco ST, Donadio MD, Almeida F, O'Connor JM, de Miguel V, Dioca M, et al. Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapy. Ecancermedicalscience. 2023;17:1523. 10.3332/ecancer.2023.1523.


78. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2023. 10.1055/a-2181-2569.


79. Nitecki R, Ramirez PT, Dundr P, Nemejcova K, Ribeiro R, Vieira Gomes MT, et al. MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial? Int J Gynecol Cancer. 2023. 10.1136/ijgc-2023-004711.


80. Niederauer Ramos CR, Silva Oliveira RJ, Rosa MN, Pereira AS, de Abreu RBV, Helvoort Lengert AV, et al. RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors. Curr Cancer Drug Targets. 2023. 10.2174/1568009623666230418101511.


81. Nguyen AX, Zahedi-Niaki G, Lando L, Hutnik CM, Wu AY. Gender and research productivity of award recipients among Canadian national ophthalmology and affiliate subspecialty societies. Womens Health (Lond). 2023;19:17455057231219613. 10.1177/17455057231219613.


82. Neuber AC, Komoto TT, da Silva ECA, Duval VDS, Scapulatempo-Neto C, Marques MMC. Quality Assessment of Cryopreserved Human Biological Samples from the Biobank of Barretos Cancer Hospital. Biopreserv Biobank. 2023;21(1):74-80. 10.1089/bio.2021.0131.


83. Nassar-Reis JP, Umeta PF, Stefano JT, Longatto-Filho A, Carrilho FJ, Alves VAF, et al. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC. J Mol Histol. 2023. 10.1007/s10735-023-10142-9.


84. Moreno IAA, Oliveira DRd, Borçoi AR, Rissatti LF, Freitas FV, Arantes LMRB, et al. Methylation of BDNF gene in association with episodic memory in women. Frontiers in Neuroscience. 2023. 10.3389/fnins.2023.1092406.


85. Moreno DA, Bonatelli M, Antoniazzi AP, de Paula FE, Leal LF, Garcia FAO, et al. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Front Oncol. 2023;13:1237170. 10.3389/fonc.2023.1237170.


86. Monção CC, Scrideli CA, Andrade AF, Viapiano MS, Carlotti CG, Moreno DA, et al. Indisulam Reduces Viability and Regulates Apoptotic Gene Expression in Pediatric High-Grade Glioma Cells. J Biomedicines. 2023;11(1):68. 10.3390/biomedicines11010068.


87. Moehler M, Xiao H, Blum SI, Elimova E, Cella D, Shitara K, et al. Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649. J Clin Oncol. 2023:Jco2300170. 10.1200/jco.23.00170.


88. Mendes AI, Fraga AG, Peixoto MJ, Aroso I, Longatto-Filho A, Marques AP, et al. Gellan gum spongy-like hydrogel-based dual antibiotic therapy for infected diabetic wounds. Bioengineering & translational medicine. 2023;8(2):1-13. 10.1002/btm2.10504.


89. McNeil MJ, Godfrey A, Loggetto P, de Oliveira Junior A, Job G, Boldrini E, et al. Physician Perceptions of and Barriers to Pediatric Palliative Care for Children With Cancer in Brazil. JCO Glob Oncol. 2023;9:e2300057. 10.1200/go.23.00057.


90. Martins TR, Witkin SS, Mendes-Correa MC, Godoy AS, Cury L, Balancin ML, et al. Impact of the covid-19 pandemic on cervical cancer screening in São Paulo State, Brazil. Acta Cytol. 2023. 10.1159/000529249.


91. Marta GN, Moraes FY, de Oliveira Franco RC, de Andrade Carvalho H, Gouveia AG, de Lima Gössling GC, et al. Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean. Rep Pract Oncol Radiother. 2023;28(3):340-51. 10.5603/RPOR.a2023.0046.


92. Marques RF, Moreno DA, da Silva L, Leal LF, de Paula FE, Santana I, et al. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Front Immunol. 2023;14:1062856. 10.3389/fimmu.2023.1062856.


93. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J. Cancer survival in the northwestern of São Paulo State, Brazil: A population-based study. Cancer Epidemiol. 2023;83:102339. 10.1016/j.canep.2023.102339.


94. Lugo LZA, Puga MAM, Jacob CMB, Padovani CTJ, Nocetti MC, Tupiná MS, et al. Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus. PLoS One. 2023;18(3):e0279390. 10.1371/journal.pone.0279390.


95. Lourenção M, Arruda GV, Rocha LP, Galendi JSC, de Oliveira JC, Jacinto AA. Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system. BMC Health Serv Res. 2023;23(1):592. 10.1186/s12913-023-09397-5.


96. Lima AB, Dos Reis MB, Matsushita M, Dos Reis MT, de Oliveira MA, Reis RM, et al. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population. Cancer Med. 2023. 10.1002/cam4.6224.


97. Lim SM, Peters S, Ortega Granados AL, Pinto GDJ, Fuentes CS, Lo Russo G, et al. Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial. Nat Commun. 2023;14(1):7301. 10.1038/s41467-023-42900-4.


98. Lando L, Mallipatna A, Kletke SN, Gallie B. Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma. Ocular Oncology and Pathology. 2023:1-7. 10.1159/000531871.


99. Komoto TT, Nishimura FG, Evangelista AF, Freitas AJAd, Silva Gd, Silva Junior WA, et al. Exploring the Therapeutic Potential of Trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells. Int J Mol Sci. 2023:1-17.


100. Kinker GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, Pereira PHB, Carvalho MLR, et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut. 2023. 10.1136/gutjnl-2022-328697.


101. Kelner M, Carvalho da Silva B, Montella T, Aguiar PN, Jr., Lopes G, Ferreira CG, et al. Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System. Value Health Reg Issues. 2023;33:1-6. 10.1016/j.vhri.2022.08.004.


102. Kawasaki MK, Prado DDd, Fonseca DdSL, Faria Morato Ld, Altei WF, van Dams R, et al. Palliative stereotactic ablative body radiotherapy reirradiation for high volume head and neck cancer. Research Square. 2023. 10.21203/


103. Julião M, Bruera E, Silva C, Calado J, Cruz M, Vaz M, et al. "Mãos de Conforto" (Hands of Comfort): A novel non-pharmacological intervention to ease agitation in elderly persons with dementia. Palliat Support Care. 2023:1-7. 10.1017/s147895152300007x.


104. Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Wyrwicz L, et al. A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus. Future Oncol. 2023. 10.2217/fon-2022-1149.


105. Igi WF, Boulhosa EBT, Afonso MPC, Mota FL. A tricky gastric lesion diagnosed by small-bowel capsule endoscopy. Endoscopy. 2023;55(S 01):E1215-e6. 10.1055/a-2208-2500.


106. Hui D, Paiva BSR, Paiva CE. Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: "Care Anywhere, Anytime". Curr Treat Options Oncol. 2023;24(1):1-11. 10.1007/s11864-022-01044-1.


107. Hermoza AD, Noleto R, Chubassi W, Pires L, da Cunha Andrade CEM, Dos Reis R. Secondary surgical cytoreduction of thoracic metastasis in a high grade serous ovarian carcinoma by video-assisted thoracoscopic surgery (VATS) in 10 steps. Gynecol Oncol Rep. 2023;46:101146. 10.1016/j.gore.2023.101146.


108. Hermoza AD, de Macêdo Matsushita G, Dos Santos MH, Schmidt RL, Dos Reis R, da Cunha Andrade CEM. Botryoid embryonal rhabdomyosarcoma of the cervix: A case report. Int J Surg Case Rep. 2023;102:107858. 10.1016/j.ijscr.2022.107858.


109. Hayashi MC, Sarri AJ, Pereira P, Rocha MM, Zequi SC, Machado MT, et al. Ergonomic risk assessment of surgeon's position during radical prostatectomy: Laparoscopic versus robotic approach. J Surg Oncol. 2023. 10.1002/jso.27419.


110. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2023. 10.1007/s10552-023-01812-w.


111. Guimarães Ribeiro A, Ferlay J, Piñeros M, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Epidemiol. 2023;85:102403. 10.1016/j.canep.2023.102403.


112. Goveia L, Castro N, de Souza C, Colaço Villarim C, Traina F, Chiattone CS, et al. Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry. Ann Hematol. 2023. 10.1007/s00277-023-05352-w.


113. Gouveia AG, Viani GA, Bratti VF, Marta GN, Hanna SA, Jacinto AA, et al. Challenges in building radiotherapy capacity: a longitudinal study evaluating eight years of the Brazilian Radiotherapy Expansion plan. J Cancer Policy. 2023:100459. 10.1016/j.jcpo.2023.100459.


114. Goncalves BT, Dos Reis R, Ribeiro R, Moretti-Marques R, Schamme FK, Oliveira GS, et al. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer? Int J Gynecol Cancer. 2023;33(10):1548-56. 10.1136/ijgc-2023-004555.


115. Gomes FC, Larcipretti ALL, Elvir FAR, Diniz JBC, de Melo TMV, Santana LS, et al. Early ambulation versus prolonged bed rest for incidental durotomies in spine procedures: a systematic review and meta-analysis. Neurosurg Rev. 2023;46(1):310. 10.1007/s10143-023-02201-2.


116. Gomes BC, Lobo SMA, LM SM, de Freitas Chaves RC, Domingos Corrêa T, Prata Amendola C, et al. Trends in perioperative practices of high-risk surgical patients over a 10-year interval. PLoS One. 2023;18(9):e0286385. 10.1371/journal.pone.0286385.


117. Gobbi MF, Ferreira MH, de Carvalho DLC, Silva GBL, Macari KSM, Neves LJ, et al. Dental consensus on HSCT - Part II: dental Care during HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.003.


118. Gholami S, Chamorro-Petronacci C, Pérez-Sayáns M, Suárez Peñaranda J, Longatto-Filho A, Baltazar F, et al. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study. J Appl Oral Sci. 2023;31:e20220461. 10.1590/1678-7757-2022-0461.


119. García-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol. 2023;18(3):313-23. 10.1016/j.jtho.2022.10.020.


120. Garcia FAO, Evangelista AF, Mançano BM, Moreno DA, Berardinelli GN, de Paula FE, et al. Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing. Cold Spring Harb Mol Case Stud. 2023;9(1). 10.1101/mcs.a006245.


121. Garcia AM, Lopes RG, Gama RR. Analysis of an institutional series of differentiated thyroid cancer in the pediatric and adolescent population. / Differentiated thyroid cancer is relatively rare in children and adolescents. Endocrinol diabetes clin exp 2023:2394 - 402.


122. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2023;906:167393. 10.1016/j.scitotenv.2023.167393.


123. Freitas AJA, Nunes CR, Mano MS, Causin RL, Santana IVV, de Oliveira MA, et al. Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial. Sci Rep. 2023;13(1):21411. 10.1038/s41598-023-48657-6.


124. Francisco LFV, da Silva RN, Oliveira MA, Dos Santos Neto MF, Gonçalves IZ, Marques MMC, et al. Occupational Exposures and Risks of Non-Hodgkin Lymphoma: A Meta-Analysis. Cancers (Basel). 2023;15(9). 10.3390/cancers15092600.


125. Francisco LFV, Baldivia DDS, Crispim BDA, Baranoski A, Klafke S, Dos Santos EL, et al. In vitro evaluation of the cytotoxic and genotoxic effects of Al and Mn in ambient concentrations detected in groundwater intended for human consumption. Ecotoxicol Environ Saf. 2023;264:115415. 10.1016/j.ecoenv.2023.115415.


126. Ferreira NN, Miranda RR, Moreno NS, Pincela Lins PM, Leite CM, Leite AET, et al. Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy. Front Bioeng Biotechnol. 2023;11:1120179. 10.3389/fbioe.2023.1120179.


127. Ferreira J, Carneiro A, Vila I, Silva C, Cunha C, Longatto-Filho A, et al. Inflammation and Loss of Skeletal Muscle Mass in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2023;88:164-73. 10.1016/j.avsg.2022.07.009.


128. Ferreira J, Afonso J, Longatto-Filho A, Roque S, Carneiro A, Vila I, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2023;99:10-8. 10.1016/j.avsg.2023.09.094.


129. Ferreira J, Afonso J, Carneiro AL, Vila I, Cunha C, Roque S, et al. Exploring the Diversity of Visceral, Subcutaneous and Perivascular Adipose Tissue in a Vascular Surgery Population. J Cardiovasc Dev Dis. 2023;10:2-17. 10.3390/jcdd10070271.


130. Ferreira D, Santos-Pereira C, Costa M, Afonso J, Yang S, Hensel J, et al. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomater Adv. 2023;154:213643. 10.1016/j.bioadv.2023.213643.


131. Ferreira CDC, Gama RR, De Carvalho AC, Santana I, Carvalho RS, Debora SDA, et al. Role of Genetic Ancestry in Oropharyngeal Squamous-Cell Carcinoma: A Cross-Sectional Study in Brazil. Journal of Biosciences Medicines. 2023;11(1):150-61. 10.4236/jbm.2023.111015.


132. Ferreira CC. The relation between human papillomavirus (HPV) and oropharyngeal cancer: a review. PeerJ. 2023;11:e15568. 10.7717/peerj.15568.


133. Ferreira BL, Ferreira DP, Borges SF, Ferreira AM, Holanda FH, Ucella-Filho JGM, et al. Diclofenac, ibuprofen, and paracetamol biodegradation: overconsumed non-steroidal anti-inflammatories drugs at COVID-19 pandemic. Front Microbiol. 2023;14:1207664. 10.3389/fmicb.2023.1207664.


134. Fernandes RT, Teixeira GR, Mamere EC, Bandeira GA, Mamere AE. The 2021 World Health Organization classification of gliomas: an imaging approach. Radiol Bras. 2023;56(3):157-61. 10.1590/0100-3984.2022.0089-en.


135. Faria EF, Machado RD, Gualberto RJC, Milani MAV, Bidinotto LT, Machado MT, et al. Patient's safety and satisfaction on same day discharge after robotic and laparoscopic radical prostatectomy versus discharge after 24 or 48 h: a longitudinal randomized prospective study. BMC Urol. 2023;23(1):149. 10.1186/s12894-023-01318-2.


136. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 2023;8(9):e691-e700. 10.1016/s2468-2667(23)00131-7.


137. Eskelinen M, Pulkkinen J, Selander T, Syrjänen K, Eskelinen M. Accuracy of Prediction Models in Diagnosis of Acute Diverticulitis. In Vivo. 2023;37(6):2597-608. 10.21873/invivo.13367.


138. Eskelinen M, Meklin J, Guimarães DP, Selander T, Syrjänen K, Eskelinen M. Fecal Immunochemical Test (FIT) in Triage of Bleed-positive (Crab+) and Bleed-negative Colorectal Adenoma (Crab-) Patients in Colorectal Neoplasia Screening. Anticancer Res. 2023;43(8):3517-28. 10.21873/anticanres.16529.


139. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. Triage Process at Endoscopy With ColonView Fecal Immunochemical Test (FIT) Will Enhance Diagnostic Accuracy (DA) of Colorectal Cancer Screening. Anticancer Res. 2023;43(12):5535-44. 10.21873/anticanres.16755.


140. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. Diagnostic Accuracy of Fecal Immunochemical Test (FIT) in Bleed-positive and Bleed-negative Colorectal Cancer (CRC) Among a Cohort of 5,090 Subjects who Participated in the Colorectal Neoplasia (CRN) Screening in Brazil. Anticancer Res. 2023;43(4):1569-80. 10.21873/anticanres.16307.


141. Dutra VGP, Silva J, Jomar RT, Silveira HCS, Muzi CD, Guimarães RM. Burden of occupational cancer in Brazil and federative units, 1990-2019. Rev Bras Epidemiol. 2023;26:e230001. 10.1590/1980-549720230001.


142. Dos Reis LR, Luiz MT, Sábio RM, Marena GD, Di Filippo LD, Duarte JL, et al. Design of rapamycin and resveratrol coloaded liposomal formulation for breast cancer therapy. Nanomedicine (Lond). 2023. 10.2217/nnm-2022-0227.


143. Donadel CD, Pires BG, André NC, Costa TCM, Orellana MD, Caruso SR, et al. Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease. Pharmaceuticals (Basel). 2023;16(4). 10.3390/ph16040512.


144. Dimopoulos MA, Moreau P, Augustson B, Castro N, Pika T, Delimpasi S, et al. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Am J Hematol. 2023;98(1):E15-e9. 10.1002/ajh.26602.


145. Diab A, Gogas H, Sandhu S, Long GV, Ascierto PA, Larkin J, et al. Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. J Clin Oncol. 2023:Jco2300172. 10.1200/jco.23.00172.


146. de Oliveira-Junior I, da Costa Vieira RA, Biller G, Sarri AJ, da Silva FCB, Nahás EAP. Factors associated with unsatisfactory cosmetic results in oncoplastic surgery. Front Oncol. 2023;13:1071127. 10.3389/fonc.2023.1071127.


147. de Oliveira WE, Jr., Murra MS, Tufi LMB, Cavalcante CEB, de Oliveira MA, da Costa RFA, et al. Sarcopenia in Children With Wilms Tumor: A Marker of Undernutrition Which May Impact Adversely on Clinical Outcomes. J Pediatr Hematol Oncol. 2023. 10.1097/mph.0000000000002732.


148. de Oliveira LC, Rosa K, Gaspar T, Paiva BSR, Paiva CE, Peres WAF. Clinical usefulness of the Patient-Generated Subjective Global Assessment and modified Glasgow Prognostic Score in decision making concerning the indication of enteral nutritional therapy in patients with incurable cancer receiving palliative care. Nutrition. 2023;112:112057. 10.1016/j.nut.2023.112057.


149. de Oliveira Klein M, Francisco LFV, Gomes INF, Serrano SV, Reis RM, Silveira HC. Hazard assessment of antineoplastic drugs and metabolites using cytotoxicity and genotoxicity assays. Mutation Research/Genetic Toxicology Environmental Mutagenesis. 2023;892:503704. 10.1016/j.mrgentox.2023.503704.


150. de Oliveira Cavagna R, de Andrade ES, Tadin Reis M, de Paula FE, Noriz Berardinelli G, Bonatelli M, et al. Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment. Sci Rep. 2023;13(1):21168. 10.1038/s41598-023-48613-4.


151. de Oliveira C, Martins SFF, Gonçalves PG, Limone GA, Longatto-Filho A, Reis RM, et al. Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer. Sci Rep. 2023;13(1):19783. 10.1038/s41598-023-47132-6.


152. de Oliveira C, Gonçalves PG, Bidinotto LT. Role of EGFL7 in human cancers: A review. J Cell Physiol. 2023. 10.1002/jcp.31084.


153. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2023;39:101818. 10.1016/j.tranon.2023.101818.


154. de Carvalho LGA, Komoto TT, Moreno DA, Goes JVC, de Oliveira RTG, de Lima Melo MM, et al. USP15-USP7 Axis and UBE2T Differential Expression May Predict Pathogenesis and Poor Prognosis in De Novo Myelodysplastic Neoplasm. Int J Mol Sci. 2023;24(12). 10.3390/ijms241210058.


155. de Camargo AV, de Mattos MD, Kawasaki MK, Gomes DNS, Borges ABB, Vazquez VL, et al. Treatment of patients with multiple brain metastases by isolated radiosurgery: Toxicity and survival. World J Clin Oncol. 2023;14(10):400-8. 10.5306/wjco.v14.i10.400.


156. da Silva FRM, Zapaterini JR, Grassi TF, Bidinotto LT, Fernandes AAH, Barbisan LF. Maternal dietary zinc status alters offspring female mammary gland development and response to acute 7,12-dimethylbenzanthracene insult. Biotech Histochem. 2023:1-12. 10.1080/10520295.2023.2196092.


157. da Costa Vieira RA, Sant'Anna D, Laus AC, Bacchi CE, Silva RJC, de Oliveira-Junior I, et al. Genetic Ancestry of 1127 Brazilian Breast Cancer Patients and Its Correlation With Molecular Subtype and Geographic Region. Clin Breast Cancer. 2023. 10.1016/j.clbc.2023.04.001.


158. da Costa Vieira RA, Ching AW, de Oliveira-Junior I. Breast reconstruction for locally advanced breast cancer previously submitted to mastectomy and an ipsilateral thoracoabdominal dermofat (ITADE) flap. Breast Dis. 2023;42(1):229-32. 10.3233/bd-220057.


159. Cruz AR, Minicucci EM, Betini M, Almeida-Lopes L, Tieghi Neto V, Cataneo AJM. Efficacy of photobiomodulation in the treatment of oral mucositis in patients undergoing antineoplastic therapy: systematic review and meta-analysis. Support Care Cancer. 2023;31(12):645. 10.1007/s00520-023-08105-7.


160. Cousseau CPV, Sorroche BP, de Jesus Teixeira R, de Carvalho AC, Melendez ME, de Castro Capuzzo R, et al. miR-99a-5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head Neck. 2023. 10.1002/hed.27459.


161. Correa Porto CRC, Longatto-Filho A, De Almeida BC, Bonetti TC, Kamaiurá SFA, Diaz RS, et al. Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus infections of lower genital tract of Indigenous women from Xingu Indigenous Park. Rural Remote Health. 2023;23(3):7126. 10.22605/rrh7126.


162. Correa MEP, Granzotto FCN, Innocentini L, Reis TC, de Lima EM, Varanda RF, et al. Brazilian dental consensus on dental management in hematopoietic stem cell transplantation - Part I - pre-HSCT. Hematol Transfus Cell Ther. 2023. 10.1016/j.htct.2023.04.001.


163. Colombo AL, Bergamasco MD, Nouér SA, Oliveira ECPT, Pasqualotto AC, de Queiroz-Telles F, et al. Invasive Aspergillosis in Patients with Acute Leukemia: Comparison Between Acute Myeloid and Acute Lymphoid Leukemia. Mycopathologia. 2023;188(1-2):1-8. 10.1007/s11046-022-00684-z.


164. Clavero E, Sanchez-Maldonado JM, Macauda A, Ter Horst R, Sampaio-Marques B, Jurczyszyn A, et al. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization. Int J Mol Sci. 2023;24(10). 10.3390/ijms24108500.


165. Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli MM, et al. Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study. Gynecol Oncol. 2023;170:195-202. 10.1016/j.ygyno.2023.01.014.


166. Cho BC, Lee JS, Wu YL, Cicin I, Dols MC, Ahn MJ, et al. Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, PD-L1-high advanced non-small cell lung cancer: a randomized, open-label, phase 3 trial. J Thorac Oncol. 2023. 10.1016/j.jtho.2023.08.018.


167. Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, et al. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023;41(18):3339-51. 10.1200/jco.22.01649.


168. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2023. 10.1053/j.gastro.2023.05.011.


169. Cavalcante CEB, Magalhães Pereira Souza F, Eiras Martins G, Milone Silva M, Pacheco Donato Macedo CR, Lederman H, et al. Diffusion-weighted imaging in pediatric extracranial germ cell tumors. PLoS One. 2023;18(11):e0294976. 10.1371/journal.pone.0294976.


170. Cavagna RO, Pinto IA, Escremim de Paula F, Berardinelli GN, Sant'Anna D, Santana I, et al. Disruptive and truncating TP53 mutations are associated with African-ancestry and worse prognosis in Brazilian patients with lung adenocarcinoma. Pathobiology. 2023. 10.1159/000530587.


171. Causin RL, Sussuchi da Silva L, Leal LF, Possati-Resende JC, Evangelista AF, Matsushita GM, et al. The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology. Cancer Cytopathol. 2023. 10.1002/cncy.22704.


172. Causin RL, Lengert AVH, Gomes INF, Freitas AJAd, Rosa MN, Reis RD, et al. MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression. Oncol Rep. 2023:1-22. 10.3892/or.2023.8546.


173. Casagrande GMS, Silva MO, Reis RM, Leal LF. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. Int J Mol Sci. 2023;24(3). 10.3390/ijms24032505.


174. Carvalho TM, Lourenção LG, Pinto MH, Viana R, Moreira A, Mello LP, et al. Quality of life and work engagement among nursing staff at the start of the COVID-19 pandemic. Cien Saude Colet. 2023;28(10):2903-13. 10.1590/1413-812320232810.09982023.


175. Cappellano AM, Dassi N, Mançano B, Epelman S, Almeida DB, Cavalheiro S, et al. Outcome of Children and Adolescents With Primary Intracranial Germinoma Treated With Chemotherapy and Reduced Dose-Field Irradiation: A Prospective Brazilian Experience. JCO Glob Oncol. 2023;9:e2200257. 10.1200/go.22.00257.


176. Campanella NC, Gomes INF, Alves ALV, Leal LF, Evangelista AF, Rosa MN, et al. Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis. Cancer Cell Int. 2023;23(1):256. 10.1186/s12935-023-03102-6.


177. Cabral ERM, Pacanhella MF, Lengert AVH, Dos Reis MB, Leal LF, de Lima MA, et al. Somatic mutation detection and KRAS amplification in testicular germ cell tumors. Front Oncol. 2023;13:1133363. 10.3389/fonc.2023.1133363.


178. Buralli R, Ribeiro A, Cremonese C, Vineis P, Meyer A. Cancer mortality and premature deaths among hairdressers in Brazil. Environ Res. 2023;244:117942. 10.1016/j.envres.2023.117942.


179. Bravo Perina L, Faria Gomes IN, Alcantara Pelloso AR, Silva VAO, Rebolho Batista Arantes LM, Eliseo Melendez M. Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines. Sci Rep. 2023;13(1):18023. 10.1038/s41598-023-44888-9.


180. Bovo AC, Pedrão PG, Guimarães YM, Godoy LR, Resende JCP, Longatto-Filho A, et al. Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review. Rev Bras Ginecol Obstet. 2023;45(12):e818-e24. 10.1055/s-0043-1776403.


181. Borges DP, Dos Santos R, Velloso ERP, Ribeiro Junior HL, Larripa IB, Camacho MF, et al. Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome. Hematol Transfus Cell Ther. 2023;45(2):147-53. 10.1016/j.htct.2021.08.002.


182. Bizzarri N, Querleu D, Dostalek L, van Lonkhuijzen L, Giannarelli D, Lopez A, et al. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study. Am J Obstet Gynecol. 2023. 10.1016/j.ajog.2023.06.030.


183. Bizzarri N, Dostálek L, van Lonkhuijzen L, Giannarelli D, Lopez A, Falconer H, et al. Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy. Obstet Gynecol. 2023;141(1):207-14. 10.1097/aog.0000000000005026.


184. Biasoli I, Castro N, Colaço Villarim C, Traina F, Chiattone CS, Praxedes M, et al. Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma Registry. EJHaem. 2023;4(4):1191-5. 10.1002/jha2.804.


185. Bermudi PMM, Pellini ACG, Diniz CSG, Ribeiro AG, de Aguiar BS, Failla MA, et al. Clusters of high-risk, low-risk, and temporal trends of breast and cervical cancer-related mortality in São Paulo, Brazil, during 2000-2016. Ann Epidemiol. 2023;78:61-7. 10.1016/j.annepidem.2022.12.009.


186. Bell M, Verberckmoes B, Devolder J, Vermandere H, Degomme O, Guimarães YM, et al. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex II HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples. Microbiol Spectr. 2023:e0008123. 10.1128/spectrum.00081-23.


187. Bastos DA, Gongora ABL, Dzik C, Jardim DL, Piva M, Carcano FM, et al. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515). Clin Genitourin Cancer. 2023;21(3):e104-e13. 10.1016/j.clgc.2022.11.004.


188. Barbosa de Sousa A, Rohr P, Silveira HCS. Analysis of mitochondrial DNA copy number variation in Brazilian farmers occupationally exposed to pesticides. Int J Environ Health Res. 2023:1-10. 10.1080/09603123.2023.2280147.


189. Bakhoum CY, Madala S, Lando L, Yarmohammadi A, Long CP, Miguez S, et al. Retinal Ischemic Perivascular Lesions in Individuals With Atrial Fibrillation. J Am Heart Assoc. 2023;12(16):e028853. 10.1161/jaha.122.028853.


190. Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, et al. Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary. Future Oncol. 2023. 10.2217/fon-2022-1294.


191. Awada Z, Cahais V, Cuenin C, Akika R, Silva Almeida Vicente AL, Makki M, et al. Waterpipe and cigarette epigenome analysis reveals markers implicated in addiction and smoking type inference. Environ Int. 2023;182:108260. 10.1016/j.envint.2023.108260.


192. Atallah FC, Caruso P, Nassar APJ, Torelly AP, Amendola CP, Salluh JIF, et al. High-value care for critically ill oncohematological patients: what do we know thus far? Crit Care Sci. 2023;35(1):84-96. 10.5935/2965-2774.20230405-en.


193. Assem NZ, Pazmiño VFC, Rodas MAR, Caliente EA, da Silva Dalben G, Soares S, et al. Bone Substitutes Graft for Regeneration of the Anterior Maxillary Alveolar Process: A Systematic Review. J Oral Implantol. 2023;49(1):102-13. 10.1563/aaid-joi-D-22-00014.


194. Arns B, Agani C, Sesin GP, Horvath JDC, Fogazzi DV, Romeiro Silva FK, et al. Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e79. 10.1017/ash.2023.136.


195. Arantes L, Silva-Oliveira RJ, de Carvalho AC, Melendez ME, Sorroche BP, de Jesus Teixeira R, et al. Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. Head Neck. 2023. 10.1002/hed.27602.


196. André T, Falcone A, Shparyk Y, Moiseenko F, Polo-Marques E, Csöszi T, et al. Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study. Lancet Gastroenterol Hepatol. 2023;8(2):133-44. 10.1016/s2468-1253(22)00334-x.


197. Andrade DAPd, Guimarães APG, Melo ACd, Nogueira-Rodrigues A, Gomes LM, Scaranti M, et al. Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil. Frontiers in Oncology. 2023;13. 10.3389/fonc.2023.1133277.


198. Andrade DAP, Veneziani AC, Paiva CE, Dos Reis R, Filho CAF, Sanches AON, et al. Discrepancies in breast cancer's oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study. Front Oncol. 2023;13:1169982. 10.3389/fonc.2023.1169982.


199. Alves MT, Cavalcanti A, Garavello I, Kososki E, Martins Silva EDFC. [Occupational performance and application of the International Classification of Functioning (ICF) in a rehabilitation service]. Rev Salud Publica (Bogota). 2023;21(3):307-16. 10.15446/rsap.V21n3.76011.


200. Alves Martins BA, Filho OM, Ghezzi TL, Melani AGF, Romagnolo LGC, Moreira Júnior H, et al. An Overview of Robotic Colorectal Surgery Adoption and Training in Brazil. Medicina (Kaunas). 2023;59(9). 10.3390/medicina59091675.


201. Aguiar Freitas AJ, Nunes CR, Mano MS, Causin RL, Calfa S, de Oliveira MA, et al. Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial. Future Oncol. 2023. 10.2217/fon-2023-0886.


202. Aguiar BS, Pellini ACG, Rebolledo EAS, Ribeiro AG, Diniz CSG, Bermudi PMM, et al. Intra-urban spatial variability of breast and cervical cancer mortality in the city of São Paulo: analysis of associated factors. Rev Bras Epidemiol. 2023;26:e230008. 10.1590/1980-549720230008.2.


203. Afonso J, Gonçalves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, et al. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. Cancers (Basel). 2023;15(3). 10.3390/cancers15030982.


204. Afonso J, Barbosa A, Pastrez PRA, Bonatelli M, da Costa RFA, Pinheiro C, et al. Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting. Pathobiology. 2023. 10.1159/000528562.

Grupos de Pesquisas